Galectin-3 is also highly abundant in stool, and fecal galectin-3 levels were increased in colorectal carcinoma patients with advanced tumor node metastasis (TNM) score, higher nuclear grade, poor tumor tissue differentiation and metastatic disease (Figure 4). Here, LGALS3 is linked to metastatic neoplasm.